Back
Nexans Vs. Moderna Industry Stock Comparison
Sell
23
NXPRF
Nexans
Last Price:
$96.77
Seasonality Move:
3.4%
Sell
21
MRNA
Moderna
Last Price:
$42.42
Seasonality Move:
19.97%
Sell
23
Nexans (NXPRF)
is a Sell
Is Nexans a Buy, Sell or Hold?
-
NXPRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NXPRF Stock Price Chart
MRNA Stock Price Chart
NXPRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.82 | Sell |
Relative Strength Index (14 RSI): | 5.42 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.55 - 114.07) | Sell |
Bollinger Bands (100): | (109.66 - 139.8) | Sell |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 47.29 | Sell |
Chaikin Money Flow: | -293401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.28 - 42.88) | Sell |
Bollinger Bands (100): | (39.14 - 65.28) | Sell |
NXPRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 99.8 | Sell |
20-day SMA: | 106.65 | Sell |
50-day SMA: | 111.77 | Sell |
200-day SMA: | 121.05 | Sell |
8-day EMA: | 99.69 | Sell |
20-day EMA: | 104.71 | Sell |
50-day EMA: | 112.41 | Sell |
200-day EMA: | 116.6 | Sell |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.11 | Buy |
20-day SMA: | 39.35 | Sell |
50-day SMA: | 40.91 | Sell |
200-day SMA: | 85.24 | Sell |
8-day EMA: | 36.96 | Buy |
20-day EMA: | 38.78 | Sell |
50-day EMA: | 43.4 | Sell |
200-day EMA: | 72.01 | Sell |
Nexans Earnings Growth & NXPRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $2.09 per share.
Nexans Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |